Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

194 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression.
Serafini P, Borrello I, Bronte V. Serafini P, et al. Among authors: bronte v. Semin Cancer Biol. 2006 Feb;16(1):53-65. doi: 10.1016/j.semcancer.2005.07.005. Epub 2005 Sep 15. Semin Cancer Biol. 2006. PMID: 16168663 Review.
Immortalized myeloid suppressor cells trigger apoptosis in antigen-activated T lymphocytes.
Apolloni E, Bronte V, Mazzoni A, Serafini P, Cabrelle A, Segal DM, Young HA, Zanovello P. Apolloni E, et al. Among authors: bronte v. J Immunol. 2000 Dec 15;165(12):6723-30. doi: 10.4049/jimmunol.165.12.6723. J Immunol. 2000. PMID: 11120790
Tumor-induced immune dysfunctions caused by myeloid suppressor cells.
Bronte V, Serafini P, Apolloni E, Zanovello P. Bronte V, et al. J Immunother. 2001 Nov-Dec;24(6):431-46. doi: 10.1097/00002371-200111000-00001. J Immunother. 2001. PMID: 11759067 Review.
Myeloid suppressor lines inhibit T cell responses by an NO-dependent mechanism.
Mazzoni A, Bronte V, Visintin A, Spitzer JH, Apolloni E, Serafini P, Zanovello P, Segal DM. Mazzoni A, et al. Among authors: bronte v. J Immunol. 2002 Jan 15;168(2):689-95. doi: 10.4049/jimmunol.168.2.689. J Immunol. 2002. PMID: 11777962
L-arginine metabolism in myeloid cells controls T-lymphocyte functions.
Bronte V, Serafini P, Mazzoni A, Segal DM, Zanovello P. Bronte V, et al. Trends Immunol. 2003 Jun;24(6):302-6. doi: 10.1016/s1471-4906(03)00132-7. Trends Immunol. 2003. PMID: 12810105 Review.
Derangement of immune responses by myeloid suppressor cells.
Serafini P, De Santo C, Marigo I, Cingarlini S, Dolcetti L, Gallina G, Zanovello P, Bronte V. Serafini P, et al. Among authors: bronte v. Cancer Immunol Immunother. 2004 Feb;53(2):64-72. doi: 10.1007/s00262-003-0443-2. Epub 2003 Oct 30. Cancer Immunol Immunother. 2004. PMID: 14593498 Review.
High-dose granulocyte-macrophage colony-stimulating factor-producing vaccines impair the immune response through the recruitment of myeloid suppressor cells.
Serafini P, Carbley R, Noonan KA, Tan G, Bronte V, Borrello I. Serafini P, et al. Among authors: bronte v. Cancer Res. 2004 Sep 1;64(17):6337-43. doi: 10.1158/0008-5472.CAN-04-0757. Cancer Res. 2004. PMID: 15342423
Nitroaspirin corrects immune dysfunction in tumor-bearing hosts and promotes tumor eradication by cancer vaccination.
De Santo C, Serafini P, Marigo I, Dolcetti L, Bolla M, Del Soldato P, Melani C, Guiducci C, Colombo MP, Iezzi M, Musiani P, Zanovello P, Bronte V. De Santo C, et al. Among authors: bronte v. Proc Natl Acad Sci U S A. 2005 Mar 15;102(11):4185-90. doi: 10.1073/pnas.0409783102. Epub 2005 Mar 7. Proc Natl Acad Sci U S A. 2005. PMID: 15753302 Free PMC article.
Regulation of immune responses by L-arginine metabolism.
Bronte V, Zanovello P. Bronte V, et al. Nat Rev Immunol. 2005 Aug;5(8):641-54. doi: 10.1038/nri1668. Nat Rev Immunol. 2005. PMID: 16056256 Review.
Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells.
Gallina G, Dolcetti L, Serafini P, De Santo C, Marigo I, Colombo MP, Basso G, Brombacher F, Borrello I, Zanovello P, Bicciato S, Bronte V. Gallina G, et al. Among authors: bronte v. J Clin Invest. 2006 Oct;116(10):2777-90. doi: 10.1172/JCI28828. J Clin Invest. 2006. PMID: 17016559 Free PMC article.
194 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback